WO2021085854A1 - 글루타치온을 생산하는 효모 균주 및 이를 이용한 글루타치온 생산방법 - Google Patents
글루타치온을 생산하는 효모 균주 및 이를 이용한 글루타치온 생산방법 Download PDFInfo
- Publication number
- WO2021085854A1 WO2021085854A1 PCT/KR2020/012614 KR2020012614W WO2021085854A1 WO 2021085854 A1 WO2021085854 A1 WO 2021085854A1 KR 2020012614 W KR2020012614 W KR 2020012614W WO 2021085854 A1 WO2021085854 A1 WO 2021085854A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- strain
- glutathione
- extract
- culture
- lysate
- Prior art date
Links
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 title claims abstract description 346
- 229960003180 glutathione Drugs 0.000 title claims abstract description 172
- 108010024636 Glutathione Proteins 0.000 title claims abstract description 152
- 240000004808 Saccharomyces cerevisiae Species 0.000 title claims abstract description 46
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 44
- 239000000203 mixture Substances 0.000 claims description 101
- 239000000284 extract Substances 0.000 claims description 78
- -1 cultures Substances 0.000 claims description 70
- 239000006166 lysate Substances 0.000 claims description 67
- 235000013305 food Nutrition 0.000 claims description 47
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 44
- 239000000463 material Substances 0.000 claims description 29
- 239000000126 substance Substances 0.000 claims description 29
- 230000003078 antioxidant effect Effects 0.000 claims description 17
- 238000012258 culturing Methods 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 16
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 16
- 239000003814 drug Substances 0.000 claims description 15
- 239000002537 cosmetic Substances 0.000 claims description 14
- 230000036039 immunity Effects 0.000 claims description 14
- 239000000654 additive Substances 0.000 claims description 13
- 239000003963 antioxidant agent Substances 0.000 claims description 13
- 201000010099 disease Diseases 0.000 claims description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 13
- 239000008194 pharmaceutical composition Substances 0.000 claims description 13
- 239000003995 emulsifying agent Substances 0.000 claims description 12
- 238000002360 preparation method Methods 0.000 claims description 10
- 230000007812 deficiency Effects 0.000 claims description 8
- 230000002708 enhancing effect Effects 0.000 claims description 8
- 230000000996 additive effect Effects 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 230000002265 prevention Effects 0.000 claims description 5
- 239000002773 nucleotide Substances 0.000 claims description 3
- 125000003729 nucleotide group Chemical group 0.000 claims description 3
- 108020004463 18S ribosomal RNA Proteins 0.000 claims description 2
- 239000012138 yeast extract Substances 0.000 description 37
- 229940041514 candida albicans extract Drugs 0.000 description 34
- 239000000047 product Substances 0.000 description 21
- 235000019640 taste Nutrition 0.000 description 20
- 239000000796 flavoring agent Substances 0.000 description 18
- 108091023242 Internal transcribed spacer Proteins 0.000 description 17
- 108020004418 ribosomal RNA Proteins 0.000 description 16
- 210000004027 cell Anatomy 0.000 description 14
- 235000011194 food seasoning agent Nutrition 0.000 description 13
- 239000002609 medium Substances 0.000 description 13
- 235000006708 antioxidants Nutrition 0.000 description 12
- 238000001784 detoxification Methods 0.000 description 12
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 11
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 11
- 239000001301 oxygen Substances 0.000 description 11
- 229910052760 oxygen Inorganic materials 0.000 description 11
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
- 150000001413 amino acids Chemical class 0.000 description 10
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 10
- 229940079593 drug Drugs 0.000 description 10
- 238000011156 evaluation Methods 0.000 description 10
- 235000019634 flavors Nutrition 0.000 description 10
- 238000009472 formulation Methods 0.000 description 10
- 239000008103 glucose Substances 0.000 description 10
- 230000001965 increasing effect Effects 0.000 description 10
- 239000000843 powder Substances 0.000 description 10
- 229940024606 amino acid Drugs 0.000 description 9
- 235000001014 amino acid Nutrition 0.000 description 9
- 235000013339 cereals Nutrition 0.000 description 9
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 8
- 102000004190 Enzymes Human genes 0.000 description 8
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 8
- 240000007594 Oryza sativa Species 0.000 description 8
- 235000007164 Oryza sativa Nutrition 0.000 description 8
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 108020004707 nucleic acids Proteins 0.000 description 8
- 150000007523 nucleic acids Chemical class 0.000 description 8
- 102000039446 nucleic acids Human genes 0.000 description 8
- 235000009566 rice Nutrition 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 7
- 235000013355 food flavoring agent Nutrition 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 239000004615 ingredient Substances 0.000 description 7
- 239000003921 oil Substances 0.000 description 7
- 235000019198 oils Nutrition 0.000 description 7
- 230000001953 sensory effect Effects 0.000 description 7
- 235000002639 sodium chloride Nutrition 0.000 description 7
- 239000000725 suspension Substances 0.000 description 7
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 6
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 6
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 6
- 229920002472 Starch Polymers 0.000 description 6
- 229930006000 Sucrose Natural products 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 239000000839 emulsion Substances 0.000 description 6
- 239000002778 food additive Substances 0.000 description 6
- 235000019668 heartiness Nutrition 0.000 description 6
- 244000005700 microbiome Species 0.000 description 6
- 108091033319 polynucleotide Proteins 0.000 description 6
- 102000040430 polynucleotide Human genes 0.000 description 6
- 239000002157 polynucleotide Substances 0.000 description 6
- 239000003755 preservative agent Substances 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 235000014347 soups Nutrition 0.000 description 6
- 235000019698 starch Nutrition 0.000 description 6
- 239000005720 sucrose Substances 0.000 description 6
- 235000019583 umami taste Nutrition 0.000 description 6
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 5
- 229920002774 Maltodextrin Polymers 0.000 description 5
- 239000005913 Maltodextrin Substances 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 239000006227 byproduct Substances 0.000 description 5
- 150000001720 carbohydrates Chemical class 0.000 description 5
- 235000014633 carbohydrates Nutrition 0.000 description 5
- 210000002421 cell wall Anatomy 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 235000013373 food additive Nutrition 0.000 description 5
- 239000008101 lactose Substances 0.000 description 5
- 229940035034 maltodextrin Drugs 0.000 description 5
- 235000012054 meals Nutrition 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000003381 stabilizer Substances 0.000 description 5
- 239000008107 starch Substances 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 4
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 4
- 241000287828 Gallus gallus Species 0.000 description 4
- 230000002292 Radical scavenging effect Effects 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 230000032683 aging Effects 0.000 description 4
- 235000019270 ammonium chloride Nutrition 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 230000000593 degrading effect Effects 0.000 description 4
- 235000015872 dietary supplement Nutrition 0.000 description 4
- 239000000945 filler Substances 0.000 description 4
- 235000013376 functional food Nutrition 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 235000010355 mannitol Nutrition 0.000 description 4
- 235000013379 molasses Nutrition 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 229920001184 polypeptide Polymers 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000000600 sorbitol Substances 0.000 description 4
- 229960002920 sorbitol Drugs 0.000 description 4
- 235000010356 sorbitol Nutrition 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 241000235646 Cyberlindnera jadinii Species 0.000 description 3
- 239000004375 Dextrin Substances 0.000 description 3
- 229920001353 Dextrin Polymers 0.000 description 3
- 239000004471 Glycine Substances 0.000 description 3
- 241001138401 Kluyveromyces lactis Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 241000939053 Saccharomyces cerevisiae YJM1592 Species 0.000 description 3
- 244000299461 Theobroma cacao Species 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 229910000019 calcium carbonate Inorganic materials 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 235000010980 cellulose Nutrition 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 210000000349 chromosome Anatomy 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- 238000012790 confirmation Methods 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 3
- 235000018417 cysteine Nutrition 0.000 description 3
- 230000009089 cytolysis Effects 0.000 description 3
- 235000019425 dextrin Nutrition 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 239000003937 drug carrier Substances 0.000 description 3
- 238000006911 enzymatic reaction Methods 0.000 description 3
- 235000013312 flour Nutrition 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 229930195712 glutamate Natural products 0.000 description 3
- 229940049906 glutamate Drugs 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 235000012149 noodles Nutrition 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 235000005985 organic acids Nutrition 0.000 description 3
- 230000002688 persistence Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 239000000829 suppository Substances 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 239000000080 wetting agent Substances 0.000 description 3
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- 244000215068 Acacia senegal Species 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- 108010023063 Bacto-peptone Proteins 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 108020004705 Codon Proteins 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 108010053070 Glutathione Disulfide Proteins 0.000 description 2
- 229920002527 Glycogen Polymers 0.000 description 2
- 229920000084 Gum arabic Polymers 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- 150000008575 L-amino acids Chemical class 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- 240000003183 Manihot esculenta Species 0.000 description 2
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- AIJULSRZWUXGPQ-UHFFFAOYSA-N Methylglyoxal Chemical compound CC(=O)C=O AIJULSRZWUXGPQ-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 235000010489 acacia gum Nutrition 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 239000003674 animal food additive Substances 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 239000006172 buffering agent Substances 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 235000016213 coffee Nutrition 0.000 description 2
- 235000013353 coffee beverage Nutrition 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 239000007857 degradation product Substances 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- 229940009714 erythritol Drugs 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 235000001727 glucose Nutrition 0.000 description 2
- 229960002989 glutamic acid Drugs 0.000 description 2
- YPZRWBKMTBYPTK-BJDJZHNGSA-N glutathione disulfide Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@H](C(=O)NCC(O)=O)CSSC[C@@H](C(=O)NCC(O)=O)NC(=O)CC[C@H](N)C(O)=O YPZRWBKMTBYPTK-BJDJZHNGSA-N 0.000 description 2
- 229940096919 glycogen Drugs 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 150000002484 inorganic compounds Chemical class 0.000 description 2
- 229910010272 inorganic material Inorganic materials 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000007951 isotonicity adjuster Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 230000002934 lysing effect Effects 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 229910000160 potassium phosphate Inorganic materials 0.000 description 2
- 235000011009 potassium phosphates Nutrition 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 150000005846 sugar alcohols Chemical class 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 235000012222 talc Nutrition 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 235000019607 umami taste sensations Nutrition 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- PAAZPARNPHGIKF-UHFFFAOYSA-N 1,2-dibromoethane Chemical compound BrCCBr PAAZPARNPHGIKF-UHFFFAOYSA-N 0.000 description 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- KZEVSDGEBAJOTK-UHFFFAOYSA-N 1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-2-[5-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]ethanone Chemical compound N1N=NC=2CN(CCC=21)C(CC=1OC(=NN=1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)=O KZEVSDGEBAJOTK-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- QMYCJCOPYOPWTI-UHFFFAOYSA-N 2-[(1-amino-1-imino-2-methylpropan-2-yl)diazenyl]-2-methylpropanimidamide;hydron;chloride Chemical compound Cl.NC(=N)C(C)(C)N=NC(C)(C)C(N)=N QMYCJCOPYOPWTI-UHFFFAOYSA-N 0.000 description 1
- YJLUBHOZZTYQIP-UHFFFAOYSA-N 2-[5-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NN=C(O1)CC(=O)N1CC2=C(CC1)NN=N2 YJLUBHOZZTYQIP-UHFFFAOYSA-N 0.000 description 1
- PWKSKIMOESPYIA-UHFFFAOYSA-N 2-acetamido-3-sulfanylpropanoic acid Chemical compound CC(=O)NC(CS)C(O)=O PWKSKIMOESPYIA-UHFFFAOYSA-N 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 235000006491 Acacia senegal Nutrition 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 239000004254 Ammonium phosphate Substances 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 208000014644 Brain disease Diseases 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- PTHCMJGKKRQCBF-UHFFFAOYSA-N Cellulose, microcrystalline Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC)C(CO)O1 PTHCMJGKKRQCBF-UHFFFAOYSA-N 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 239000001512 FEMA 4601 Substances 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 208000023105 Huntington disease Diseases 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- HELXLJCILKEWJH-SEAGSNCFSA-N Rebaudioside A Natural products O=C(O[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@]1(C)[C@@H]2[C@](C)([C@H]3[C@@]4(CC(=C)[C@@](O[C@H]5[C@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@H](O)[C@@H](CO)O5)(C4)CC3)CC2)CCC1 HELXLJCILKEWJH-SEAGSNCFSA-N 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 235000012501 ammonium carbonate Nutrition 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 229910000148 ammonium phosphate Inorganic materials 0.000 description 1
- 235000019289 ammonium phosphates Nutrition 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 235000021405 artificial diet Nutrition 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 229960003563 calcium carbonate Drugs 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 1
- 239000001527 calcium lactate Substances 0.000 description 1
- 235000011086 calcium lactate Nutrition 0.000 description 1
- 229960002401 calcium lactate Drugs 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- 235000012241 calcium silicate Nutrition 0.000 description 1
- 235000011132 calcium sulphate Nutrition 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 235000019519 canola oil Nutrition 0.000 description 1
- 239000000828 canola oil Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 239000008119 colloidal silica Substances 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 235000021186 dishes Nutrition 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 244000013123 dwarf bean Species 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- HELXLJCILKEWJH-UHFFFAOYSA-N entered according to Sigma 01432 Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC(C1OC2C(C(O)C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O HELXLJCILKEWJH-UHFFFAOYSA-N 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 235000019264 food flavour enhancer Nutrition 0.000 description 1
- 235000003086 food stabiliser Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000004459 forage Substances 0.000 description 1
- 235000013611 frozen food Nutrition 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- 235000021331 green beans Nutrition 0.000 description 1
- 235000001497 healthy food Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 239000012676 herbal extract Substances 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001341 hydroxy propyl starch Substances 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 235000013828 hydroxypropyl starch Nutrition 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 230000006799 invasive growth in response to glucose limitation Effects 0.000 description 1
- FBAFATDZDUQKNH-UHFFFAOYSA-M iron chloride Chemical compound [Cl-].[Fe] FBAFATDZDUQKNH-UHFFFAOYSA-M 0.000 description 1
- 229910000358 iron sulfate Inorganic materials 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 235000019573 kokumi flavor Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000000832 lactitol Substances 0.000 description 1
- 235000010448 lactitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 1
- 229960003451 lactitol Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- VMPHSYLJUKZBJJ-UHFFFAOYSA-N lauric acid triglyceride Natural products CCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC)COC(=O)CCCCCCCCCCC VMPHSYLJUKZBJJ-UHFFFAOYSA-N 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 239000011812 mixed powder Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 235000019575 mouthfulness Nutrition 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 239000012457 nonaqueous media Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 239000006186 oral dosage form Substances 0.000 description 1
- 125000001477 organic nitrogen group Chemical group 0.000 description 1
- 150000002898 organic sulfur compounds Chemical class 0.000 description 1
- 235000016046 other dairy product Nutrition 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- YPZRWBKMTBYPTK-UHFFFAOYSA-N oxidized gamma-L-glutamyl-L-cysteinylglycine Natural products OC(=O)C(N)CCC(=O)NC(C(=O)NCC(O)=O)CSSCC(C(=O)NCC(O)=O)NC(=O)CCC(N)C(O)=O YPZRWBKMTBYPTK-UHFFFAOYSA-N 0.000 description 1
- 150000002927 oxygen compounds Chemical class 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 229920001522 polyglycol ester Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 235000021395 porridge Nutrition 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 235000019203 rebaudioside A Nutrition 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 235000019643 salty taste Nutrition 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 108010027322 single cell proteins Proteins 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000019614 sour taste Nutrition 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000002676 xenobiotic agent Substances 0.000 description 1
- 230000002034 xenobiotic effect Effects 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
- 239000007222 ypd medium Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/064—Saccharomycetales, e.g. baker's yeast
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/14—Yeasts or derivatives thereof
- A23L33/145—Extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A61K38/063—Glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
- C12N1/18—Baker's yeast; Brewer's yeast
- C12N1/185—Saccharomyces isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/30—Other Organic compounds
- A23V2250/31—Glutathione
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/76—Yeasts
- A23V2250/762—Saccharomyces
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
- C12R2001/85—Saccharomyces
- C12R2001/865—Saccharomyces cerevisiae
Definitions
- the present application relates to a yeast strain producing a novel glutathione and a method for producing glutathione using the same.
- Glutathione is an organic sulfur compound most commonly present in cells. It is a tripeptide form that combines three amino acids: glycine, glutamate, and cysteine.
- Glutathione exists in two forms in the body: reduced glutathione (GSH) and oxidized glutathione (GSSG).
- GSH reduced glutathione
- GSSG oxidized glutathione
- Reduced glutathione (GSH) which is present in a relatively high proportion under general circumstances, is mainly distributed in the liver and skin cells of the human body, has an antioxidant function that decomposes and removes active oxygen, detoxification such as removal of exogenous compounds such as toxic substances, melanin pigment It plays an important role, such as whitening, which inhibits production.
- glutathione having various functions is in the spotlight as a material in various fields such as pharmaceuticals, health functional foods, and cosmetics, and is also used to manufacture taste ingredients, food and feed additives. It is known that glutathione has a great effect of increasing the taste of the raw material and maintaining rich taste persistence, and can be used alone or as a flavor enhancer of kokumi in combination with other substances. Usually, Kokumi materials have a richer feeling than umami materials such as existing nucleic acids and MSG, and are known to be produced by decomposing and aging proteins.
- the object of the present application is to provide a novel Saccharomyces cerevisiae strain that produces glutathione.
- Another object of the present application is to provide a method for producing glutathione comprising the step of culturing the strain.
- Another object of the present application is the step of culturing the strain and mixing one or more substances and additives selected from among the cultivated strains, dried products thereof, extracts, cultures, lysates, and glutathione recovered from them; It provides a method for preparing a composition containing glutathione, including.
- Another object of the present application is the strain; Dry matter, extract, culture, lysate of the strain; And glutathione recovered from any one or more of the strain, dry matter, extract, culture, and lysate; It provides a composition for antioxidant function, detoxification, immunity enhancing, cosmetic, food, feed containing one or more substances selected from.
- the strain Dry matter, extract, culture, lysate of the strain; And glutathione recovered from any one or more of the strain, dry matter, extract, culture, and lysate; It is to provide a pharmaceutical composition or pharmaceutical composition used for the prevention or treatment of diseases caused by glutathione deficiency, including one or more substances selected from among them.
- the strain of the present application can produce a remarkably large amount of glutathione compared to the existing glutathione-producing strain. Therefore, the strain of the present application can be usefully used in the production of glutathione.
- the strain of the present application Dry matter, extract, culture, lysate of the strain; And glutathione recovered from any one or more of the strain, dry matter, extract, culture, and lysate; Since the composition comprising at least one material selected from has excellent active oxygen removal ability, it can be usefully used as a composition for antioxidant function, detoxification, and immunity enhancement.
- composition may be usefully used in a cosmetic composition, a pharmaceutical composition, and the manufacture thereof.
- compositions and feed compositions when used in food, not only the above-described functions but also the taste of the food are excellent, and thus it can be usefully used in preparing food compositions and feed compositions.
- One aspect of the present application may provide a novel Saccharomyces cerevisiae strain producing glutathione.
- the glutathione-producing strain of the present application may be a Saccharomyces cerevisiae CJ-5 strain with accession number KCCM12568P.
- the glutathione-producing strain of the present application is another homogeneous Saccharomyces cerevisiae, specifically, Saccharomyces cerevisiae, or Saccharomyces cerevisiae 18S (ITS, 5.8S) rRNA sequence of YJM1592 ( It may include an 18S (ITS, 5.8S) rRNA sequence having at least 90%, specifically 91%, 92%, 93%, 93.2%, 93.5% or 93.7% homology or identity with SEQ ID NO: 3), but , Is not limited thereto.
- the glutathione-producing strain of the present application is 90% or more of the 18S (ITS, 5.8S) rRNA sequence of YJM1592, specifically 91%, 92%, 93%, 93.2%, 93.5%, or 93.7% or more. It may include, but is not limited to, an 18S (ITS, 5.8S) rRNA sequence having homology or identity and less than 96%, 95.5%, or 95.2% identity.
- the 18S (ITS, 5.8S) rRNA sequence is an ITS (Internal transcribed spacer) sequence that exists between 18S rRNA and 5.8S, and is a sequence used for species classification.
- the glutathione-producing strain of the present application may have an 18S (ITS, 5.8S) rRNA sequence of SEQ ID NO: 1.
- the 18S (ITS, 5.8S) rRNA sequence of the strain is 90% or more with SEQ ID NO: 1, specifically 95%, 96%. It may have a homology or identity of 97%, 98%, or 99% or more, but is not limited thereto.
- the term'homology' or'identity' means the degree to which two given amino acid sequences or base sequences are related, and may be expressed as a percentage.
- the terms homology and identity can often be used interchangeably.
- sequence homology or identity of a conserved polynucleotide or polypeptide is determined by standard alignment algorithms, and the default gap penalty established by the program used can be used together.
- Substantially, homologous or identical (identical) sequences are generally in moderate or high stringent conditions along at least about 50%, 60%, 70%, 80% or 90% of the sequence or full-length. (stringent conditions) can be hybridized. Hybridization is also contemplated for polynucleotides containing degenerate codons instead of codons in the polynucleotide.
- the homology, similarity, or identity of a polynucleotide or polypeptide can be found in, for example, Smith and Waterman, Adv. Appl. As known in Math (1981) 2:482, for example, Needleman et al. (1970), J Mol Biol. 48: It can be determined by comparing sequence information using a GAP computer program such as 443.
- the GAP program is defined as the total number of symbols in the shorter of the two sequences, divided by the number of similarly aligned symbols (ie, nucleotides or amino acids).
- Default parameters for the GAP program are (1) binary comparison matrix (contains values of 1 for identity and 0 for non-identity) and Schwartz and Dayhoff, eds., Atlas Of Protein Sequence And Structure, National Biomedical Research Foundation , pp. As disclosed by 353-358 (1979), Gribskov et al (1986) Nucl. Acids Res. 14: weighted comparison matrix of 6745 (or EDNAFULL (EMBOSS version of NCBI NUC4.4) substitution matrix); (2) a penalty of 3.0 for each gap and an additional 0.10 penalty for each symbol in each gap (or a gap opening penalty of 10, a gap extension penalty of 0.5); And (3) no penalty for end gaps.
- Glutathione is used interchangeably with “glutathione” and “GSH”, and refers to a tripeptide composed of three amino acids: glutamate, cysteine, and glycine. Glutathione may be used as a raw material for pharmaceuticals, health functional foods, taste ingredients, foods, feed additives, cosmetics, etc., but is not limited thereto.
- the novel Saccharomyces cerevisiae strain of the present application is characterized by high glutathione-producing ability.
- the strain may be a strain having enhanced glutathione-producing ability, a strain having high glutathione-producing ability, or a strain having increased glutathione-producing ability.
- strain producing glutathione of the present application may be used interchangeably with terms such as "a strain having glutathione-producing ability” and “glutathione-producing strain”.
- the Saccharomyces cerevisiae strain according to the present invention contains at least 0.6% by weight, specifically at least 0.7% by weight, at least 0.8% by weight, at least 0.9% by weight, at least 1.0% by weight, and at least 1.1% by weight of glutathione based on the weight of the dry cells. It may be included, but is not limited thereto.
- Another aspect of the present application may provide a composition for producing glutathione comprising the strain.
- glutathione production to “glutathione production” may include accumulating glutathione in cells.
- the composition for producing glutathione is a composition capable of producing glutathione by the strain of the present application.
- the composition includes the strain, and further includes, without limitation, a composition capable of producing glutathione by using the strain. I can.
- composition for producing glutathione of the present application may further include any suitable additives commonly used in the composition for producing glutathione.
- the additive may be naturally derived or non-naturally occurring, but is not limited thereto.
- the additives may include excipients and/or emulsifiers.
- the excipients may be appropriately selected and used according to the intended use or form, for example, starch, glucose, cellulose, lactose, glycogen, D-mannitol, sorbitol, lactitol, maltodextrin, calcium carbonate, synthetic aluminum silicate, Calcium monohydrogen phosphate, calcium sulfate, sodium chloride, sodium hydrogen carbonate, purified lanolin, dextrin, sodium alginate, methylcellulose, colloidal silica gel, hydroxypropyl starch, hydroxypropylmethylcellulose, propylene glycol, casein, calcium lactate , Primogel, and gum arabic may be selected, and specifically, may be one or more components selected from starch, glucose, cellulose, lactose, dextrin, glycogen, D-mannitol, and maltodextrin, but is not limited thereto.
- Emulsifiers are glycerol ester, susorbitan ester, monoglyceride, diglyceride, triglyceride, sucrose ester, sorbitan ester, propelin glycol ester, glycerin fatty acid ester, sorbitan fatty acid ester, propylene glycol fatty acid ester, sucrose fatty acid ester , Lecithin or a mixture thereof may be used, but is not limited thereto, and those known in the art may be appropriately used.
- the excipient may include, for example, a preservative, a wetting agent, a dispersing agent, a suspending agent, a buffering agent, a stabilizer, or an isotonic agent, but is not limited thereto.
- Another aspect of the present application may provide a method for producing glutathione comprising the step of culturing the strain.
- Glutathione may be accumulated in the cells through the culture of the strain.
- any medium and other culture conditions used for culturing the strain of the present application may be used without particular limitation as long as it is a medium used for culturing a microorganism of the genus Saccharomyces.
- the strain of the present application may be used as a suitable carbon source, It can be cultured while controlling temperature, pH, etc. under aerobic or anaerobic conditions in a conventional medium containing nitrogen sources, personnel, inorganic compounds, amino acids and/or vitamins.
- the carbon source includes carbohydrates such as glucose, fructose, sucrose, maltose, and the like; Sugar alcohols such as mannitol and sorbitol, organic acids such as pyruvic acid, lactic acid, and citric acid; Amino acids such as glutamic acid, methionine, and lysine may be included, but are not limited thereto.
- natural organic nutrients such as starch hydrolyzate, molasses, black strap molasses, rice winter, cassava, sugarcane residue and corn steep liquor can be used, and glucose and sterilized pretreated molasses (i.e. molasses converted to reducing sugar)
- Carbohydrates such as, etc. may be used, and other appropriate amounts of carbon sources may be used in various ways without limitation. These carbon sources may be used alone or in combination of two or more.
- nitrogen source examples include inorganic nitrogen sources such as ammonia, ammonium sulfate, ammonium chloride, ammonium acetate, ammonium phosphate, ammonium carbonate, and ammonium nitrate; Organic nitrogen sources such as amino acids, peptone, NZ-amine, meat extract, yeast extract, malt extract, corn steep liquor, casein hydrolyzate, fish or its degradation products, skim soybean cake or its degradation products, and the like can be used. These nitrogen sources may be used alone or in combination of two or more, but are not limited thereto.
- inorganic nitrogen sources such as ammonia, ammonium sulfate, ammonium chloride, ammonium acetate, ammonium phosphate, ammonium carbonate, and ammonium nitrate
- Organic nitrogen sources such as amino acids, peptone, NZ-amine, meat extract, yeast extract, malt extract, corn steep liquor, casein hydrolyzate, fish or its degradation products, skim soybean cake or its degradation products, and the
- the personnel may include first potassium phosphate, second potassium phosphate, or a sodium-containing salt corresponding thereto.
- the inorganic compound sodium chloride, calcium chloride, iron chloride, magnesium sulfate, iron sulfate, manganese sulfate, calcium carbonate, and the like may be used.
- the medium may contain amino acids, vitamins and/or suitable precursors.
- L-amino acids, etc. may be added to the culture medium of the strain.
- glycine, glutamate, and/or cysteine may be added, and if necessary, L-amino acids such as lysine may be further added, but not necessarily limited thereto. Does not.
- the medium or precursor may be added to the culture in a batch or continuous manner, but is not limited thereto.
- a compound such as ammonium hydroxide, potassium hydroxide, ammonia, phosphoric acid, or sulfuric acid may be added to the culture in an appropriate manner during the culture of the strain, so that the pH of the culture can be adjusted.
- foaming can be suppressed by using an antifoaming agent such as fatty acid polyglycol ester.
- oxygen or oxygen-containing gas may be injected into the culture, or nitrogen, hydrogen, or carbon dioxide gas may be injected without the injection of gas to maintain the anaerobic and microaerobic state.
- the temperature of the culture may be 25°C to 40°C, and more specifically 28°C to 37°C, but is not limited thereto.
- the cultivation period may be continued until the production amount of the desired useful substance is obtained, and specifically, may be 1 hour to 100 hours, but is not limited thereto.
- the method for producing glutathione may further include an additional process after the culturing step.
- the additional process may be appropriately selected depending on the use of glutathione.
- the method for producing glutathione may include recovering glutathione from at least one material selected from the strain, a dried product thereof, an extract, a culture product, and a lysate after the culturing step.
- culture may be a result obtained by culturing the strain of the present application.
- it may be a medium containing by-products generated through metabolism by ingesting nutrients by culturing a strain in a medium, and a dilution or concentrate of the medium, a dried product obtained by drying the medium, a preparation or purification of the medium
- It includes cultures of all formulations that can be formed using the medium, such as water or a mixture thereof.
- the culture of the microorganism of the present application may or may not include the microorganism. The culture is as described above.
- the "lysate” may be a result obtained by crushing or lysing the strain or a culture thereof, or a supernatant obtained by centrifuging the lysate.
- the cultures, lysates, their supernatant and their fractions are also included in the scope of the present application.
- the method may further include lysing the strain before or simultaneously with the recovery step.
- the lysis of the strain may be performed by a method commonly used in the technical field to which the present application belongs, for example, a lysis buffer solution, a sonicator, heat treatment, and a French press.
- the lysis step may include, but is not limited to, enzymatic reactions such as cell wall degrading enzyme, nucleic acid degrading enzyme, nucleic acid transfer enzyme, and proteolytic enzyme.
- dry yeast, yeast extract, yeast extract mix powder, pure purified glutathione containing a high content of glutathione through the glutathione production method glutathione may be prepared, but is not limited thereto, and may be appropriately prepared according to the desired product.
- dry yeast may be used interchangeably with terms such as "dry strain”.
- the dry yeast may be prepared by drying yeast cells accumulating glutathione, and specifically, may be included in a composition for feed, a composition for food, etc., but is not limited thereto.
- yeast extract may be used interchangeably with terms such as "strain extract".
- the strain extract may mean a material remaining after separating the cell wall from the cells of the strain. Specifically, it may mean the remaining components excluding the cell wall from the components obtained by lysis of the cells.
- the strain extract includes glutathione, and components other than glutathione may include one or more components of protein, carbohydrate, nucleic acid, and fiber, but are not limited thereto.
- glutathione which is a target substance, may be recovered using a suitable method known in the art.
- the recovery step may include a purification process.
- the purification process may be pure purification by separating only glutathione from the strain. Through the purification process, pure glutathione may be prepared.
- the method for producing glutathione may further include mixing an additive with a substance selected from among strains obtained after the culturing step, dried products thereof, extracts, cultures, lysates, and glutathione recovered from them.
- a yeast extract mix powder may be prepared through the mixing step.
- the additives may include excipients and/or emulsifiers. Excipients and emulsifiers can be appropriately selected and used by those skilled in the art, and examples thereof are as described above.
- the step of culturing the strain And mixing a substance and an additive selected from the cultured strain, a dried product thereof, an extract, a culture product, a lysate product, and a glutathione recovered therefrom. Including, it can provide a method for preparing a composition comprising glutathione.
- composition of the present application may further include a naturally occurring material or a non-naturally occurring material.
- the substance may include, but is not limited to, a pharmaceutically acceptable carrier, a food pharmaceutically acceptable carrier, a cosmetically acceptable carrier, and the like, depending on the intended use of the composition.
- the carrier can be appropriately selected by a person skilled in the art based on known contents.
- the content of the material selected from the strain of the present application, the dried product thereof, the extract, the culture product, the lysate and the glutathione recovered from the total composition relative to the total composition may be 3 to 30% by weight of the total composition weight.
- the additives may include excipients and/or emulsifiers. Excipients and emulsifiers can be appropriately selected and used by those skilled in the art, and examples thereof are as described above.
- the strain Dry matter, extract, culture, lysate of the strain; And glutathione recovered from any one or more of the strain, dry matter, extract, culture, and lysate; It can provide a composition for antioxidant, detoxification, immunity enhancing, cosmetic, food or feed containing one or more substances selected from among.
- the strain Dry matter, extract, culture, lysate of the strain; And glutathione recovered from any one or more of the strain, dry matter, extract, culture, and lysate; It is possible to provide a method of preparing a composition for antioxidant, detoxification, immunity enhancing, cosmetic, food or feed containing one or more substances selected from among.
- the composition may include the strain itself, and may include a culture of the strain, a dried product of the strain, an extract of the strain, a lysate of the strain, and a culture of the strain, an extract, Glutathione may be recovered from the dried product or the crushed product to include it, but is not limited thereto. That is, since the strain, its dried product, extract, culture, and lysate contain glutathione, the form containing glutathione may vary slightly depending on the specific use of the composition, but as long as the content of the desired glutathione can be increased. , May be included in any form without limitation.
- the content of the material selected from the strain of the present application, the dried product thereof, the extract, the culture product, the lysate and the glutathione recovered from the total composition relative to the total composition may be 3 to 30% by weight of the total composition weight.
- the composition may further contain any suitable additives commonly used in the composition.
- the composition is a strain producing glutathione of the present application; Dry matter, extract, culture, lysate of the strain; And glutathione recovered from any one or more of the strain, dry matter, extract, culture, and lysate; Including one or more of the substances may have an increased glutathione content.
- the strain Dry matter, extract, culture, lysate of the strain; And glutathione recovered from any one or more of the strain, dry matter, extract, culture, and lysate; It is possible to provide a composition for an antioxidant function, including one or more substances selected from among.
- Antioxidation in the present application may mean an action to inhibit, reduce or control the generation of oxidation reactions occurring in nature in a broad range, and more specifically, free radicals generated in the body, generated from the free radicals It may mean an action of inhibiting, reducing or controlling the generation or reaction of hydrogen peroxide or peroxide, or a hydroxy radical generated from the hydrogen peroxide.
- the strain Dry matter, extract, culture, lysate of the strain; And glutathione recovered from any one or more of the strain, dry matter, extract, culture, and lysate; It is possible to provide a composition for detoxification, including one or more substances selected from among.
- Detoxification of the present application may include all actions of removing or reducing toxicity caused by harmful substances.
- Glutathione is an endogenous antioxidant produced by cells, and not only directly involved in the neutralization of free radicals and active oxygen compounds, but also can maintain exogenous antioxidants such as vitamins C and E in a reduced form, so the detoxification is active. Oxygen to free radicals, hydrogen peroxide or peroxide generated from the free radicals, and the production or reaction of hydroxy radicals generated from the hydrogen peroxide may be suppressed, reduced or controlled.
- glutathione can protect the thiol group of cellular proteins, thereby preventing side effects caused by overdose of drugs such as acetaminophen, and is also used to detoxify methylglyoxal, which is produced as a metabolic by-product, thereby reducing the toxicity of the compound. Alleviating or reducing can also be included in the scope of the detoxification.
- the strain Dry matter, extract, culture, lysate of the strain; And glutathione recovered from any one or more of the strain, dry matter, extract, culture, and lysate; It may provide a composition for enhancing immunity, including one or more substances selected from among.
- the term "immunity enhancement" in the present application is to enhance the biological defense against an antigen, and specifically, may mean increasing cellular and humoral immunity against the antigen, and specifically, the immunity compared to before administration of the composition. This can mean an increase.
- the mechanism of immunity enhancement is not limited, but may include, for example, promoting the activity of antigen-providing cells such as macrophages or promoting specific activity for lymphocytes.
- glutathione has strong antioxidant power, improves liver function, and may play a role in helping the decomposition of toxic substances in the body. It can remove harmful free radicals and participate in the immune system. That is, glutathione increases the activity of T lymphocytes and leukocytes, thereby enhancing immunity in the body and recovering the vitality of individuals debilitated by various chronic diseases, etc., a strain containing glutathione of the present application; Dry matter, extract, culture, lysate of the strain; And glutathione recovered from any one or more of the strain, dry matter, extract, culture, and lysate; One or more substances selected from among them may be usefully used for enhancing immunity.
- the strain Dry matter, extract, culture, lysate of the strain; And glutathione recovered from any one or more of the strain, dry matter, extract, culture, and lysate; It is possible to provide a cosmetic composition comprising one or more substances selected from among.
- the "cosmetic composition” of the present application is a solution, external ointment, cream, foam, nutrient lotion, soft lotion, pack, softening water, emulsion, makeup base, essence, liquid detergent, bathing agent, sunscreen cream, sun oil, suspension, Emulsion, paste, gel, lotion, powder, soap, surfactant-containing cleansing, oil, powder foundation, emulsion foundation, wax foundation, can be prepared in a formulation selected from the group consisting of a patch and spray, but is not limited thereto. Does not.
- the cosmetic composition may additionally include one or more cosmetically acceptable carriers that are blended in general skin cosmetics, and as common ingredients, for example, oil, water, surfactants, moisturizers, lower alcohols, thickeners, chelates Agents, pigments, preservatives, fragrances, and the like may be appropriately blended, but are not limited thereto.
- a cosmetically acceptable carrier included in the cosmetic composition of the present application may be appropriately selected by a person skilled in the art according to the formulation of the cosmetic composition.
- the strain Dry matter, extract, culture, lysate of the strain; And glutathione recovered from any one or more of the strain, dry matter, extract, culture, and lysate; It is possible to provide a food composition comprising one or more materials selected from.
- the food composition may be one containing the cells or extract of the strain of the present application, and more specifically, may be used by formulating it in an appropriate form including an additive in the strain extract depending on the food to be applied.
- the strain extract is as described above.
- the additives may include excipients and/or emulsifiers. Excipients and emulsifiers can be appropriately selected and used by those skilled in the art, and examples thereof are as described above. It may also contain food supplements, food stabilizers, moisture preservatives, and the like.
- the "food composition” of the present application may include all forms such as functional food, nutritional supplement, healthy food, and food additives.
- composition for food of this type can be prepared in various forms according to conventional methods known in the art.
- the food composition includes the form of pills, powders, granules, needles, tablets, capsules, liquids, etc., and foods to which the composition of the present application can be added include, for example, various foods, such as rice. , Edible grain flour (edible grain flour), grain soup, rice bowl, noodles, soup, instant rice, seasoning, lunchbox rice, dry cooked rice, bread, edible sugar, rice cake, bibimjang, sauce, spices, edible salt, Seasoning, seasoning powder, processed, frozen, dried and cooked fruits and vegetables, jellies, jams, candied fruits, eggs, milk and other dairy products, edible fats and oils, coffee, cocoa and coffee substitutes, tapioca , Grain flour and grain preparations, ramen, udon, noodles, kalguksu, cold noodles, porridge, soup, soup dishes, instant foods (instant foods), frozen foods, retort foods, other beverages, gum, tea, vitamin complexes, health supplements, etc.
- various foods such as rice.
- the food composition of the present application may contain various herbal extracts, food supplements, or natural carbohydrates as an additional ingredient, as in ordinary foods.
- the food additives may include food additives conventional in the art, for example, flavoring agents, flavoring agents, coloring agents, fillers, stabilizers, and the like.
- natural carbohydrates examples include monosaccharides such as glucose, fructose, and the like; Disaccharides such as maltose, sucrose, and the like; And polysaccharides, for example, common sugars such as dextrin and cyclodextrin, and sugar alcohols such as xylitol, sorbitol, and erythritol.
- natural flavoring agents for example, rebaudioside A, glycyrrhizin, etc.
- synthetic flavoring agents sacharin, aspartame, etc.
- conventional food additives used for the purpose of supplementing taste and nutrition for example, nucleic acids, amino acids, organic acids, and the like may be added.
- the food composition of the present application includes various nutrients, vitamins, minerals (electrolytes), flavors such as synthetic flavors and natural flavors, coloring agents and fillers (cheese, chocolate, etc.), pectic acid and salts thereof, alginic acid, and It may contain salts, organic acids, protective colloidal thickeners, pH adjusters, stabilizers, preservatives, glycerin, alcohols, carbonates used in carbonated beverages, and the like. In addition, it may contain natural fruit juice and flesh for the production of fruit juice beverages and vegetable beverages. These components may be used independently or in combination.
- the food product of the present application can be prepared by a method commonly used in the art, and during the production, raw materials and ingredients commonly added in the art may be added to prepare it.
- the formulation of the food may be prepared without limitation as long as it is a formulation recognized as a food.
- the food composition of the present application when used as a health functional food, the food composition of the present application may be prepared in various forms of formulation, and unlike general drugs, which may occur when taking the drug for a long time using food as a raw material. It has the advantage of no side effects, and is excellent in portability, and the food of the present application can be ingested as a supplement.
- the food composition of the present application may also include flavoring agents, flavoring agents, coloring agents, fillers, stabilizers, and seasoning materials that can be classified as food additives.
- the term'flavor' in the present application may be a material added to enhance the flavor of food.
- the seasoning material may be a material that allows the food to have excellent taste.
- the seasoning material may be divided according to taste components. That is, depending on the flavor, it can be divided into a neutral seasoning material, a beef seasoning material, a chicken seasoning material, a pork seasoning material, and a kokumi seasoning material.
- 'Kokumi flavor' refers to a seasoning material that produces kokumi, and'kokumi' is a word derived from Japanese, and in English,'mouthfulness','continuity','thickness', ' It is also expressed as'heartiness', and in Korean, it can mean a taste expressed as'deep taste','thick taste','fill in the mouth','rich taste', and'real taste'.
- 'Neutral flavor' refers to a seasoning material that maximizes umami and minimizes other flavors to produce a mild and clean flavor.For example, oils such as canola oil or grapeseed oil are used as a neutral flavor. It can be referred to as having.
- 'Pureness' may mean that it has a sour taste, sweet taste, salty taste, bitter taste, umami taste, etc., but is not limited thereto.
- the food composition of the present application may contain 3 to 30% by weight of the yeast extract of the present application relative to the total weight of the composition, and may further include at least one component selected from ammonium chloride, maltodextrin, powdered crystalline glucose, and an emulsifier. have.
- the food composition comprises 3 to 25% by weight of yeast extract based on the total weight of the composition, 20 to 35% by weight of ammonium chloride, 25 to 35% by weight of maltodextrin, 3 to 7% by weight per powder crystal glucose, It may contain 0.1 to 1% by weight of an emulsifier, but is not limited thereto.
- the strain Dry matter, extract, culture, lysate of the strain; And glutathione recovered from any one or more of the strain, dry matter, extract, culture, and lysate; It is possible to provide a feed composition comprising one or more materials selected from.
- the composition for feed may include any one or more of the strain itself, strain dried product, and strain extract of the present application, or may include a cell wall component obtained in the process of preparing the extract of the strain, for example It may include a strain dry matter (dry yeast) and / or strain extract (yeast extract), but is not limited thereto.
- the "feed composition" of the present application is any natural or artificial diet, one meal meal, etc. or a component of the one meal meal for animals to eat, ingest, and digest, and yeast with an increased glutathione content according to the present application
- the feed comprising a can be prepared in various types of feed known in the art, specifically, may include a thick feed, forage and / or special feed.
- the kind of feed is not particularly limited, and feed commonly used in the art may be used.
- Non-limiting examples of the feed include vegetable feeds such as grains, root fruits, food processing by-products, algae, fiber, pharmaceutical by-products, oils, starches, meals or grain by-products; And animal feeds such as proteins, inorganic logistics, minerals, oils, single-cell proteins, zooplanktons or food. These may be used alone or in combination of two or more.
- Another aspect of the present application is, including glutathione recovered from any one or more of the strain, its dry matter, extract, culture, lysate, the strain, dry matter, extract, culture, lysate, caused by glutathione deficiency It is possible to provide a pharmaceutical composition for use in the prevention or treatment of diseases.
- Another aspect of the present application is, including glutathione recovered from any one or more of the strain, its dry matter, extract, culture, lysate, the strain, dry matter, extract, culture, lysate, caused by glutathione deficiency It is possible to provide a pharmaceutical composition used for the prevention or treatment of a disease.
- the "pharmaceutical composition” may be a chemical or biological compound or substance for use in medical diagnosis, treatment, treatment or prevention of a disease or pathology, or a mixture or combination of two or more such compounds or substances.
- a pharmaceutical composition for manufacturing is used in the same meaning as a pharmaceutical composition, or may mean a composition further including any additional ingredients necessary for pharmaceutical manufacturing and/or formulation. However, it is not limited thereto.
- glutathione contributes to the antioxidant function of decomposing and removing free radicals, detoxification and enhancing immunity, so the strain, its culture, dried product, extract, and lysate contain glutathione at a high concentration, making it useful for pharmaceutical manufacturing. It can be used, and the drug can be usefully used to treat diseases caused by glutathione deficiency.
- strains, their cultures, dried products, extracts, and lysates contain glutathione at a high concentration, and thus may themselves be included in a component of a pharmaceutical composition for preventing or treating diseases caused by glutathione deficiency.
- the disease is not limited as long as it is a disease caused by glutathione deficiency.
- a disease is caused by accumulation of free radicals and/or decreased immunity, and specifically, degenerative neurological diseases including atherosclerosis, Lou Gehrig's disease, Parkinson's disease, Alzheimer's, amyotrophic sclerosis and Huntington's disease, Myocardial infarction, angina, coronary artery disease, cardiovascular disease including ischemic heart disease, ischemic brain disease including stroke, digestive system disease including diabetes, gastritis and gastric cancer, cancer, leukemia, cataract, aging, rheumatoid arthritis, hepatitis , Atopic dermatitis, etc., but is not limited thereto.
- the drug and/or pharmaceutical composition may further include a pharmaceutically acceptable carrier.
- a pharmaceutically acceptable carrier may mean exhibiting properties that are not toxic to cells or humans exposed to the drug.
- the carrier may be used without limitation as long as it is known in the art such as a buffering agent, a preservative, a painless agent, a solubilizing agent, an isotonic agent, a stabilizer, a base agent, an excipient, and a lubricant.
- the pharmaceuticals and/or pharmaceutical compositions are formulated in the form of oral dosage forms such as powders, granules, tablets, capsules, suspensions, emulsions, syrups, aerosols, etc., external preparations, suppositories, and sterile injectable solutions, respectively, according to conventional methods. It may be an edification. Further, it may be used in the form of an ointment, lotion, spray, patch, cream, powder, suspension, gel or gel for external skin.
- Carriers, excipients, and diluents that may be included in the pharmaceuticals of the present application include lactose, dextrose, sucrose, sorbitol, mannitol, xylitol, erythritol, maltitol, starch, gum acacia, alginate, gelatin, calcium phosphate, calcium silicate, Cellulose, methyl cellulose, microcrystalline cellulose, polyvinyl pyrrolidone, water, methylhydroxybenzoate, propylhydroxybenzoate, talc, magnesium stearate and mineral oils.
- diluents or excipients such as fillers, extenders, binders, wetting agents, disintegrants, and surfactants that are usually used.
- Solid preparations for oral administration include tablets, pills, powders, granules, capsules, and the like, and these solid preparations include at least one excipient in the composition, such as starch, calcium carbonate, and sucrose. ) Or lactose (lactose), gelatin, etc. are mixed and prepared. In addition to simple excipients, lubricants such as magnesium stearate and talc are also used.
- Liquid preparations for oral use include water and liquid paraffin, which are simple diluents commonly used for suspensions, liquid solutions, emulsions, syrups, etc., and various excipients such as wetting agents, sweetening agents, fragrances, and preservatives. have.
- Formulations for parenteral administration include sterilized aqueous solutions, non-aqueous solutions, suspensions, emulsions, lyophilized formulations, and suppositories.
- non-aqueous solvent and suspending agent propylene glycol, polyethylene glycol, vegetable oil such as olive oil, and injectable ester such as ethyl oleate may be used.
- injectable ester such as ethyl oleate
- a base for suppositories witepsol, macrogol, tween 61, cacao butter, laurin paper, glycerogelatin, and the like may be used.
- the drug and/or pharmaceutical composition may be administered in a pharmaceutically effective amount.
- administration in the present application means introducing a predetermined substance to an individual by an appropriate method, and the administration route of the composition may be administered through any general route as long as it can reach the target tissue.
- Intraperitoneal administration, intravenous administration, intramuscular administration, subcutaneous administration, intradermal administration, oral administration, topical administration, intranasal administration, intrapulmonary administration, and rectal administration may be administered, but are not limited thereto.
- the term "individual” may mean all animals including humans, such as mice, mice, and livestock. Specifically, it may be a mammal including a human.
- pharmaceutically effective amount refers to an amount sufficient to treat a disease at a reasonable benefit/risk ratio applicable to medical treatment and does not cause side effects, and the effective dose level is the sex, age, and weight of the patient. , Health condition, type of disease, severity, activity of the drug, sensitivity to the drug, method of administration, time of administration, route of administration, and rate of excretion, duration of treatment, factors including drugs used in combination or simultaneously, and other medical fields. It can be readily determined by a person skilled in the art according to known factors. Administration may be administered once a day at the recommended dosage, or may be divided several times.
- Another aspect of the present application may provide the use of the strain for producing glutathione.
- the strain is as described above.
- Example 1 Selection of strains with excellent glutathione production and confirmation of glutathione production ability
- a strain having high glutathione-producing ability was selected by obtaining a strain from yeast containing various strains and improving it.
- grain samples such as rice, barley, green beans, and oats were collected from a total of 20 regions, including Hwaseong, Pyeongtaek, Icheon, Yongin, Gyeonggi-do, Korea to make yeast.
- the collected grain samples were pulverized, kneaded, wrapped in a cloth, pressed firmly to form, wrapped with straw, fermented for 10 days, and then dried slowly to prepare yeast.
- Experiments were performed as follows to isolate various strains from the prepared yeast. 45 ml of saline was added to 5 g of yeast and pulverized with a mixer.
- the pure yeast strain was serial dilution and spread on YPD Agar (Yeast extract 10 g/L, Bacto peptone 20 g/L, Glucose 20 g/L, based on 1 liter of distilled water) and cultured at 30° C. for 48 hours. In addition, yeast colony was streaked on YPD agar through colony morphology and microscopic verification. 25 ml of YPD broth was dispensed into a 250 ml Erlenmeyer flask, and the pure isolated strain was inoculated, followed by shaking culture (30° C., 200 rpm) for 48 hours to check the glutathione production amount, and strain screening was performed.
- YPD Agar Yeast extract 10 g/L, Bacto peptone 20 g/L, Glucose 20 g/L, based on 1 liter of distilled water
- yeast colony was streaked on YPD agar through colony morphology and microscopic verification. 25
- a random mutation was induced in the isolated strain.
- a strain having a glutathione production amount of 15 mg/L was isolated and named as CJ-37 strain. After culturing the CJ-37 strain on a solid medium, it was inoculated into broth to obtain a culture solution, and UV irradiation was performed on the cells using a UV lamp. Thereafter, the UV-irradiated culture medium was plated on a plate medium to separate and obtain only mutant strains that formed colonies, and their glutathione production was confirmed.
- the glutathione production amount of the mutant strain was up to 105 mg/L, and the strain showing the best glutathione production (105 mg/L) was selected as the glutathione-producing strain and named as CJ-5 strain. It was deposited with the Korean Culture Center of Microorganisms (KCCM) on July 31, 2019, and was given the deposit number KCCM12568P.
- KCCM Korean Culture Center of Microorganisms
- Example 1 In order to confirm the glutathione-producing ability of the CJ-5 strain selected in Example 1, the GSH-producing ability was compared and analyzed by culturing with three known microorganisms (Table 1) in the following manner. As a control, the CJ-37 strain obtained in Example 1 was also cultured and analyzed for comparison.
- CJ-5 strain had the best GSH content compared to the cells.
- CJ-5 strain is Candida utilis KCCM50667 strain, Kluyveromyces lactis ATCC8585 strain, and Saccharomyces cerevisiae CEN.
- the GSH content relative to the cells was about 200%-300% or more, so the glutathione production ability was very excellent, and in particular, compared to CJ-37, the GSH production ability was improved by about 584%.
- the CJ-5 strain has excellent GSH production ability, and it can be seen that the strain of the present application can be usefully used for GSH production.
- the 18S (ITS, 5.8S) ribosomal RNA (rRNA) nucleotide sequence of the strain was compared for similarity using the BLAST database (http://www.ncbi.nlm.nih.gob/blast/).
- the 18S (ITS, 5.8S) rRNA sequence of CJ-5 strain is SEQ ID NO: 1
- the 18S (ITS, 5.8S) rRNA sequence of CJ-37 strain is SEQ ID NO: 2
- Saccharomyces cerevisiae YJM1592 chromosome XII 18S (ITS, 5.8 S) rRNA sequence is shown in SEQ ID NO: 3.
- the CJ-5 strain showed 93.73% similarity to the Saccharomyces cerevisiae YJM1592 chromosome XII 18S (ITS, 5.8S) rRNA sequence.
- the CJ-37 strain also showed 95.20% similarity to the Saccharomyces cerevisiae YJM1592 chromosome XII 18S (ITS, 5.8S) rRNA sequence.
- strain of the present application has high GSH-producing ability, and the strain, its dried product, extract, culture and/or lysate can be used in various cosmetics, foods, feeds, etc. using GSH as a raw material.
- yeast extract containing glutathione Saccharomyces cerevisiae CEN.PK2-1D, CJ-5, and CJ-37 yeast cultures were first centrifuged with a centrifuge.
- the centrifuged yeast was washed twice and centrifuged to obtain yeast. After that, cell wall degrading enzyme, nucleic acid degrading enzyme, nucleic acid transfer enzyme, and proteolytic enzyme were added, followed by enzymatic reaction at a pH of 5.2 and a temperature of 45°C for 48 hours.
- the enzyme in the supernatant was heat-treated at 85° C. for 30 minutes to inactivate, and the supernatant in which the enzyme was inactivated was concentrated to prepare a yeast extract.
- Saccharomyces cerevisiae CEN.PK2-1D, CJ-5, and CJ-37 yeast extracts contained 0.8%, 2.2%, and 0.4% of glutathione relative to the total weight.
- Example 5 Sensory evaluation of food composition containing glutathione
- Sensory evaluation of the food composition was performed, including the yeast extract prepared in Example 4. Specifically, for the sensory evaluation of the Saccharomyces cerevisiae CEN.PK2-1D, CJ-5, and CJ-37 yeast extracts, sensory evaluation was performed based on consome chicken soup.
- Sensory evaluation was conducted by making a consomme chicken soup mixture containing 5% of each of the yeast extract as a target for sensory testers. The evaluation was evaluated for persistence of taste (gokumi), umami (umami), bitterness (already), increase in chicken taste, soft and deep taste, and overall preference.
- the CJ-5 yeast extract had superior taste persistence (gokumi) and softer and deeper taste than the CEN.PK2-1D yeast extract and CJ-37 yeast extract, and the overall acceptability was increased ( Fig. 1).
- the yeast extract of the present application can be usefully used in manufacturing a food composition excellent in taste, the yeast strain; Dry matter, extract, culture, lysate of the strain; And glutathione recovered from any one or more of the strain, dry matter, extract, culture, and lysate; It can be seen that one or more materials selected from among them can also be usefully used in preparing food compositions.
- Example 6-1 Evaluation of radical scavenging ability
- the radical scavenging ability of the yeast extract containing glutathione was evaluated.
- the yeast extract exhibited excellent antioxidant activity, the yeast strain; Dry matter, extract, culture, lysate of the strain; And glutathione recovered from any one or more of the strain, dry matter, extract, culture, and lysate; It can be seen that one or more substances selected from among them can be usefully used for antioxidant, detoxification and immunity enhancement.
- yeast extract mixed powder having a content ratio of 3-30% yeast extract, 20-40% ammonium chloride, 20-40% maltodextrin, 1-10% powdered crystalline glucose, and 0.1-1% emulsifier was prepared.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- General Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Wood Science & Technology (AREA)
- Botany (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Birds (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Nutrition Science (AREA)
- Animal Husbandry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medical Informatics (AREA)
- Immunology (AREA)
- Alternative & Traditional Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physiology (AREA)
Abstract
Description
균주 |
1. Candida utilis KCCM50667 |
2. Kluyveromyces lactis ATCC8585 |
3 Saccharomyces cerevisiae CEN.PK2-1D |
Strain | 16hr | 24hr | ||
OD600 | OD600 | GSH(mg/L) | GSH함량(%) | |
Candida utilis KCCM50667 | 72.0 | 65.8 | 80.3 | 0.59 |
Kluyveromyces lactis ATCC8585 | 81.0 | 74.2 | 99.0 | 0.65 |
Saccharomyces cerevisiae CEN.PK2-1D | 28.9 | 39.0 | 31.3 | 0.39 |
CJ-37 | 35.4 | 37.2 | 14.6 | 0.19 |
CJ-5 | 41.0 | 46.0 | 105.2 | 1.11 |
Claims (15)
- 글루타치온을 생산하는 기탁번호 KCCM12568P인 사카로마이세스 세레비지애(Saccharomyces cerevisiae) 균주.
- 제1항에 있어서, 상기 균주는 서열번호 1의 염기서열을 18S rRNA 서열로 포함하는, 균주.
- 제1항의 균주를 배양하는 단계를 포함하는, 글루타치온 제조방법.
- 제3항에 있어서, 상기 배양된 균주, 상기 균주의 건조물, 상기 균주의 추출물, 상기 균주의 배양물, 및 상기 균주의 파쇄물 중에서 선택된 하나 이상의 물질로부터 글루타치온을 회수하는 단계를 추가로 포함하는, 글루타치온 제조방법.
- 제1항의 균주를 배양하는 단계; 및상기 배양된 균주, 이의 건조물, 추출물, 배양물, 파쇄물 및 이들로부터 회수된 글루타치온 중에서 선택된 하나 이상의 물질과 첨가제를 혼합하는 단계;를 포함하는, 글루타치온 포함 조성물의 제조방법.
- 제5항에 있어서, 상기 첨가제는 부형제 또는 유화제를 포함하는, 글루타치온 포함 조성물의 제조방법.
- 제5항에 있어서, 상기 배양된 균주, 이의 건조물, 추출물, 배양물, 파쇄물 및 이들로부터 회수된 글루타치온 중에서 선택된 하나 이상의 물질의 중량은 전체 조성물 중량 대비 3 내지 30 중량 % 인, 글루타치온 포함 조성물의 제조방법.
- 제1항의 균주; 상기 균주의 건조물, 추출물, 배양물, 파쇄물; 및 상기 균주, 건조물, 추출물, 배양물, 파쇄물 중 어느 하나 이상으로부터 회수된 글루타치온; 중에서 선택된 하나 이상의 물질을 포함하는, 항산화 기능용 조성물.
- 제1항의 균주; 상기 균주의 건조물, 추출물, 배양물, 파쇄물; 및 상기 균주, 건조물, 추출물, 배양물, 파쇄물 중 어느 하나 이상으로부터 회수된 글루타치온; 중에서 선택된 하나 이상의 물질을 포함하는, 해독용 조성물.
- 제1항의 균주; 상기 균주의 건조물, 추출물, 배양물, 파쇄물; 및 상기 균주, 건조물, 추출물, 배양물, 파쇄물 중 어느 하나 이상으로부터 회수된 글루타치온; 중에서 선택된 하나 이상의 물질을 포함하는, 면역 증강용 조성물.
- 제1항의 균주; 상기 균주의 건조물, 추출물, 배양물, 파쇄물; 및 상기 균주, 건조물, 추출물, 배양물, 파쇄물 중 어느 하나 이상으로부터 회수된 글루타치온; 중에서 선택된 하나 이상의 물질을 포함하는, 화장품용 조성물.
- 제1항의 균주; 상기 균주의 건조물, 추출물, 배양물, 파쇄물; 및 상기 균주, 건조물, 추출물, 배양물, 파쇄물 중 어느 하나 이상으로부터 회수된 글루타치온; 중에서 선택된 하나 이상의 물질을 포함하는, 식품용 조성물.
- 제1항의 균주; 상기 균주의 건조물, 추출물, 배양물, 파쇄물; 및 상기 균주, 건조물, 추출물, 배양물, 파쇄물 중 어느 하나 이상으로부터 회수된 글루타치온; 중에서 선택된 하나 이상의 물질을 포함하는, 사료용 조성물.
- 제1항의 균주; 상기 균주의 건조물, 추출물, 배양물, 파쇄물; 및 상기 균주, 건조물, 추출물, 배양물, 파쇄물 중 어느 하나 이상으로부터 회수된 글루타치온; 중에서 선택된 하나 이상의 물질을 포함하는, 글루타치온 결핍에 기인하는 질환의 예방 또는 치료에 사용되는 의약품 제조용 조성물.
- 제1항의 균주; 상기 균주의 건조물, 추출물, 배양물, 파쇄물; 및 상기 균주, 건조물, 추출물, 배양물, 파쇄물 중 어느 하나 이상으로부터 회수된 글루타치온; 중에서 선택된 하나 이상의 물질을 포함하는, 글루타치온 결핍에 기인하는 질환의 예방 또는 치료용 약학적 조성물.
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MYPI2022002141A MY197207A (en) | 2019-10-29 | 2020-09-18 | Yeast strain producing glutathione and method of producing glutathione using the same |
CA3155978A CA3155978A1 (en) | 2019-10-29 | 2020-09-18 | Yeast strain producing glutathione and method of producing glutathione using the same |
MX2022004952A MX2022004952A (es) | 2019-10-29 | 2020-09-18 | Cepa de levadura productora de glutation y procedimiento de produccion de glutation mediante el uso de la misma. |
JP2022521443A JP7377353B2 (ja) | 2019-10-29 | 2020-09-18 | グルタチオンを生産する酵母菌株及びそれを用いたグルタチオン生産方法 |
US17/773,001 US20220387532A1 (en) | 2019-10-29 | 2020-09-18 | Yeast strain producing glutathione and method of producing glutathione using the same |
CN202080076006.0A CN114761539B (zh) | 2019-10-29 | 2020-09-18 | 生产谷胱甘肽的酵母菌株和使用其生产谷胱甘肽的方法 |
EP20882475.5A EP4026895A4 (en) | 2019-10-29 | 2020-09-18 | YEAST STRAIN THAT PRODUCES GLUTATHIONE AND GLUTATHIONE PRODUCTION METHOD USING THE SAME |
BR112022008206A BR112022008206A2 (pt) | 2019-10-29 | 2020-09-18 | Cepa de levedura que produz glutationa e método de produção de glutationa com uso da mesma |
AU2020374138A AU2020374138A1 (en) | 2019-10-29 | 2020-09-18 | Yeast Strain Producing Glutathione And Method Of Producing Glutathione Using The Same |
ZA2022/04733A ZA202204733B (en) | 2019-10-29 | 2022-04-28 | Yeast strain producing glutathione and method of producing glutathione using the same |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190135659A KR102222210B1 (ko) | 2019-10-29 | 2019-10-29 | 글루타치온을 생산하는 효모 균주 및 이를 이용한 글루타치온 생산방법 |
KR10-2019-0135659 | 2019-10-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2021085854A1 true WO2021085854A1 (ko) | 2021-05-06 |
Family
ID=75164145
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2020/012614 WO2021085854A1 (ko) | 2019-10-29 | 2020-09-18 | 글루타치온을 생산하는 효모 균주 및 이를 이용한 글루타치온 생산방법 |
Country Status (14)
Country | Link |
---|---|
US (1) | US20220387532A1 (ko) |
EP (1) | EP4026895A4 (ko) |
JP (1) | JP7377353B2 (ko) |
KR (1) | KR102222210B1 (ko) |
CN (1) | CN114761539B (ko) |
AR (1) | AR120099A1 (ko) |
AU (1) | AU2020374138A1 (ko) |
BR (1) | BR112022008206A2 (ko) |
CA (1) | CA3155978A1 (ko) |
MX (1) | MX2022004952A (ko) |
MY (1) | MY197207A (ko) |
TW (1) | TWI732686B (ko) |
WO (1) | WO2021085854A1 (ko) |
ZA (1) | ZA202204733B (ko) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102503474B1 (ko) * | 2020-04-29 | 2023-02-28 | 주식회사 대호 | 가축용 성장촉진제 |
KR102593542B1 (ko) | 2021-06-10 | 2023-10-26 | 씨제이제일제당 주식회사 | 슈퍼옥사이드 디스뮤테이즈 1 변이체 및 이를 이용한 글루타치온 또는 그 유도체의 생산방법 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004180509A (ja) * | 2002-11-29 | 2004-07-02 | Kanegafuchi Chem Ind Co Ltd | グルタチオン高含有酵母およびそれを培養して得られる食品又は医薬品、又は化粧品用素材 |
KR20100095829A (ko) * | 2009-02-23 | 2010-09-01 | 대한민국(농촌진흥청장) | 글루타치온을 고농도로 생산하는 사카로마이세스 세레비시애의 돌연변이체 및 이를 배양하여 글루타치온을 대량 생산하는 방법 |
KR20100097885A (ko) * | 2009-02-27 | 2010-09-06 | 대한민국(농촌진흥청장) | 글루타치온 고발현 사카로마이세스 세레비지애 54-8 야생형및 이의 용도 |
KR20120127153A (ko) * | 2011-05-12 | 2012-11-21 | (주)창조바이오텍 | 글루타치온을 고발현하는 효모 균주 및 이의 용도 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5881797A (ja) * | 1981-11-10 | 1983-05-17 | Kyowa Hakko Kogyo Co Ltd | グルタチオンの製造法 |
JP2003159048A (ja) * | 2001-11-26 | 2003-06-03 | Ajinomoto Co Inc | γ−グルタミルシステイン産生酵母とそのスクリーニング法 |
CN1313597C (zh) * | 2004-10-17 | 2007-05-02 | 肖强 | 一种生物工程法生产谷胱甘肽的方法 |
US7371557B2 (en) * | 2006-02-22 | 2008-05-13 | Food Industry Research And Development Institute | Saccharomyces cerevisiae strains for hyper-producing glutathione and γ-glutamylcysteine and processes of use |
CN101024818B (zh) * | 2006-02-22 | 2011-12-07 | 财团法人食品工业发展研究所 | 用于高产谷胱甘肽与其前体的酿酒酵母菌株及其使用方法 |
KR20100040589A (ko) * | 2008-10-10 | 2010-04-20 | 동아대학교 산학협력단 | 글루타치온의 대량 생산방법 |
KR101612421B1 (ko) * | 2013-12-18 | 2016-04-14 | (주)푸른들이엠사료 | 글루타치온을 고발현하는 신규 균주 및 글루타치온 대량 생산 방법 |
CN105505801A (zh) * | 2015-12-25 | 2016-04-20 | 湖北泱盛生物科技有限公司 | 一种高产谷胱甘肽的酿酒酵母及其用途 |
CN107058139A (zh) * | 2016-10-11 | 2017-08-18 | 北京科慧通智慧科技有限公司 | 一株高产谷胱甘肽的酵母菌株 |
-
2019
- 2019-10-29 KR KR1020190135659A patent/KR102222210B1/ko active IP Right Grant
-
2020
- 2020-09-18 US US17/773,001 patent/US20220387532A1/en active Pending
- 2020-09-18 MX MX2022004952A patent/MX2022004952A/es unknown
- 2020-09-18 EP EP20882475.5A patent/EP4026895A4/en active Pending
- 2020-09-18 WO PCT/KR2020/012614 patent/WO2021085854A1/ko unknown
- 2020-09-18 CA CA3155978A patent/CA3155978A1/en active Pending
- 2020-09-18 BR BR112022008206A patent/BR112022008206A2/pt active Search and Examination
- 2020-09-18 AU AU2020374138A patent/AU2020374138A1/en active Pending
- 2020-09-18 JP JP2022521443A patent/JP7377353B2/ja active Active
- 2020-09-18 MY MYPI2022002141A patent/MY197207A/en unknown
- 2020-09-18 CN CN202080076006.0A patent/CN114761539B/zh active Active
- 2020-09-22 TW TW109132754A patent/TWI732686B/zh active
- 2020-09-28 AR ARP200102682A patent/AR120099A1/es unknown
-
2022
- 2022-04-28 ZA ZA2022/04733A patent/ZA202204733B/en unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004180509A (ja) * | 2002-11-29 | 2004-07-02 | Kanegafuchi Chem Ind Co Ltd | グルタチオン高含有酵母およびそれを培養して得られる食品又は医薬品、又は化粧品用素材 |
KR20100095829A (ko) * | 2009-02-23 | 2010-09-01 | 대한민국(농촌진흥청장) | 글루타치온을 고농도로 생산하는 사카로마이세스 세레비시애의 돌연변이체 및 이를 배양하여 글루타치온을 대량 생산하는 방법 |
KR20100097885A (ko) * | 2009-02-27 | 2010-09-06 | 대한민국(농촌진흥청장) | 글루타치온 고발현 사카로마이세스 세레비지애 54-8 야생형및 이의 용도 |
KR20120127153A (ko) * | 2011-05-12 | 2012-11-21 | (주)창조바이오텍 | 글루타치온을 고발현하는 효모 균주 및 이의 용도 |
Non-Patent Citations (13)
Title |
---|
"Atlas Of Protein Sequence And Structure", 1979, NATIONAL BIOMEDICAL RESEARCH FOUNDATION, pages: 353 - 358 |
"Guide to Huge Computers", 1994, ACADEMIC PRESS |
ATSCHUL, S. F. ET AL., J. MOL. BIOL., vol. 215, 1990, pages 403 |
CARILLO ET AL., SIAM.! APPLIED MATH, vol. 48, 1988, pages 1073 |
DATABASE NUCLEOTIDE 31 July 2018 (2018-07-31), ANONYMOUS: "Saccharomyces cerevisiae IFM 40211 genes for 18S rRNA, ITS1, 5.8S rRNA, ITS2, 28S rRNA, partial and complete sequence", XP055807188, retrieved from GENBANK Database accession no. LC413772 * |
DEVEREUX, J. ET AL., NUCLEIC ACIDS RESEARCH, vol. 12, 1984, pages 387 |
GRIBSKOV ET AL., NUCL. ACIDS RES., vol. 14, 1986, pages 6745 |
NEEDLEMAN ET AL., J. MOL. BIOL., vol. 48, 1970, pages 443 |
NEEDLEMANWUNSCH, J. MOL. BIOI., vol. 48, 1970, pages 443 - 453 |
PEARSON ET AL., PROC. NATL. ACAD. SCI. USA, vol. 85, 1988, pages 2444 |
RICE, TRENDS GENET, vol. 16, 2000, pages 276 - 277 |
SIPES IG ET AL.: "The role of glutathione in the toxicity of xenobiotic compounds: metabolic activation of 1,2-dibromoethane by glutathione", ADV EXP MED BIOL., vol. 197, 1986, pages 457 - 67 |
SMITHWATERMAN, ADV. APPL. MATH, vol. 2, 1981, pages 482 |
Also Published As
Publication number | Publication date |
---|---|
MX2022004952A (es) | 2022-05-16 |
ZA202204733B (en) | 2023-07-26 |
MY197207A (en) | 2023-05-31 |
US20220387532A1 (en) | 2022-12-08 |
CA3155978A1 (en) | 2021-05-06 |
EP4026895A4 (en) | 2023-02-15 |
JP2022552488A (ja) | 2022-12-16 |
AR120099A1 (es) | 2022-02-02 |
AU2020374138A1 (en) | 2022-05-05 |
KR102222210B1 (ko) | 2021-03-05 |
JP7377353B2 (ja) | 2023-11-09 |
TW202128981A (zh) | 2021-08-01 |
TWI732686B (zh) | 2021-07-01 |
CN114761539A (zh) | 2022-07-15 |
CN114761539B (zh) | 2023-11-14 |
EP4026895A1 (en) | 2022-07-13 |
BR112022008206A2 (pt) | 2022-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2017074037A1 (ko) | 효소 생산능이 우수한 전통 발효식품 유래 신규 균주 및 이를 이용하여 곡물 발효 효소식품을 제조하는 방법 | |
WO2021085854A1 (ko) | 글루타치온을 생산하는 효모 균주 및 이를 이용한 글루타치온 생산방법 | |
WO2018062914A1 (ko) | 신규한 락토바실러스 사케이 및 이를 포함하는 조성물 | |
WO2013108972A1 (ko) | 발효 옥수수 단백질 가수분해물 및 이의 제조방법 | |
WO2020130471A1 (ko) | 체중 또는 체지방 감소 효능을 갖는 신규 유산균 및 이의 용도 | |
EP3483281A1 (en) | Extracellular polysaccharide of lactic acid bacteria and use thereof | |
WO2023055188A1 (ko) | 신규 프로바이오틱스 및 이의 용도 | |
KR102387028B1 (ko) | 알파-글루코시다아제 저해제를 생산하는 신규한 바실러스 코아귤란스 cc 균주 | |
WO2018186710A1 (ko) | 최종당화산물 저감 활성을 갖는 신규한 균주 및 이의 용도 | |
KR100734975B1 (ko) | 1-데옥시노지리마이신을 생산하는 바실러스 서브틸리스s10 균주 및 이를 유효성분으로 함유하는 조성물 | |
WO2015041498A1 (ko) | 네오아가로올리고당을 포함하는 면역 증강용 또는 항암용 조성물 | |
WO2016072655A1 (ko) | 결명자 유산균 발효물을 유효성분으로 하는 변비 개선, 치료 또는 예방용 조성물 및 그 제조방법 | |
WO2014196775A1 (ko) | 락토바실러스 브레비스 g-101 및 이의 용도 | |
WO2023014054A1 (ko) | 블라우티아 속 균주, 류코노스톡 속 균주 또는 루미노코쿠스 속 균주 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도 | |
WO2022158641A1 (ko) | 신규 리조푸스 올리고스포러스 균주 및 이를 포함하는 항균 조성물 | |
WO2023058801A1 (ko) | 락토바실러스 애시도필러스 kbl402 또는 kbl409 균주를 포함하는 장 질환 개선, 예방 또는 치료용 조성물 | |
WO2017065546A1 (ko) | 3,6-안하이드로-l-갈락토오스의 항충치 용도 | |
RU2800992C1 (ru) | Продуцирующий глутатион штамм дрожжей и способ получения глутатиона с его использованием | |
TW202241480A (zh) | 用於提高記憶學習功能及/或認知功能以及抑制記憶學習功能及/或認知功能降低的組成物 | |
WO2021182808A1 (ko) | 야로위아 속 변이체 및 이를 이용한 지방의 제조 방법 | |
WO2019203540A2 (ko) | 다중불포화지방산의 멀티-하이드록시 유도체 생산 방법 | |
WO2022060204A1 (ko) | 바실러스 효소군 이용 생물전환된 기능성 약콩분말을 유효성분으로 포함하는 조성물 및 이의 용도 | |
WO2024049115A1 (ko) | 녹용 효소분해 추출물(henkiv®)을 이용한 운동수행능력 향상 또는 피로 회복용 식품 조성물 | |
WO2020145651A1 (ko) | 비타민 b1 및 b2를 고함량으로 함유하는 맥주효모 추출물 및 이의 제조방법 | |
WO2024039163A1 (ko) | 고함량의 단백질, 항산화 색소 및 오메가-3 지방산을 포함하는 바이오매스를생산하는 신규한 스키조키트리움 속 균주 및 이의 용도 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 20882475 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2022521443 Country of ref document: JP Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2020882475 Country of ref document: EP Effective date: 20220408 |
|
ENP | Entry into the national phase |
Ref document number: 3155978 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2020374138 Country of ref document: AU Date of ref document: 20200918 Kind code of ref document: A |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112022008206 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 112022008206 Country of ref document: BR Kind code of ref document: A2 Effective date: 20220428 |